MedTrace Logo

Retrospective Study of Trabectedin in Soft Tissue Sarcomas

NCT02793050 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 510

Last updated 2019-05-10

No results posted yet for this study

Summary

This is an independent, observational, retrospective post marketing study on the use of trabectedin in a clinical setting.

A data collection on the clinical use of the drug will help to improve knowledge and might contribute to optimize the clinical use of the drug.

Conditions

  • Sarcoma, Soft Tissue

Interventions

DRUG

Trabectedin

Collection of data on the clinical use of Trabectedin

Sponsors & Collaborators

  • Italian Sarcoma Group

    lead NETWORK

Principal Investigators

  • Stefano Ferrari, MD · Italian Sarcoma Group

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-15
Primary Completion
2018-10-02
Completion
2018-10-02

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02793050 on ClinicalTrials.gov